✦ LIBER ✦

Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical Trials

✍ Scribed by D. C. Brennan; C. Legendre; D. Patel; K. Mange; A. Wiland; K. McCague; F. S. Shihab

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lower incidence of cytomegalovirus infec

✍ M. Viganò; T. Dengler; M.F. Mattei; A. Poncelet; J. Vanhaecke; E. Vermes; R. Kle 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Three-Year Efficacy and Safety Results f

✍ Štefan Vítko; Raimund Margreiter; Willem Weimar; Jacques Dantal; Dirk Kuypers; M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Wound events in kidney transplant patien

✍ Cooper, M.; Wiseman, A. C.; Zibari, G.; McCague, K.; Kim, Y.; Geissler, F.; Nash 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

401: Everolimus Versus Mycophenolatemofe

✍ M. Strueber; F. Stefan; A.R. Simon; G. Warnecke; M. Dierich; A. Haverich; T. Wel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Prospective Clinical Trial Comparing Two

✍ E. Favi; F. Citterio; G. Spagnoletti; A. Gargiulo; F. Delreno; J. Romagnoli; M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 113 KB